Sojat, Antoan Stefan
Mayo Clinic
National Centre for Infertility and Endocrinology of Gender, Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Centre of Serbia, Belgrade 11000, Serbia.
Citations 2
Obesity in menopause care
Hulsteijn, Leonie T. van , Dekkers, Olaf M. , Hirschberg, A, Jayasena, Channa , Louwers, Yvonne V. , Pinkerton, JoAnn V. , Šojat, Antoan Stefan , Lumsden, Mary Ann , van Hulsteijn, Leonie , Dekkers, Olaf M , Jayasena, Channa N , Sojat, Antoan Stefan , Lambrinoudaki, Ιrene , Faubion, Stephanie S. , Hirschberg, Angelica Lindén
European Journal of Endocrinology | January 2, 2026 | Volume: 194 | Issue: 1 | Pages: L14-L15
European Society of Endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause
Lumsden, Mary Ann , Dekkers, Olaf M. , Jayasena, Channa , Louwers, Yvonne V. , Pinkerton, JoAnn V. , Šojat, Antoan Stefan , Hulsteijn, Leonie T. van , Jayasena, Channa N , Lambrinoudaki, Irene , Sojat, Antoan Stefan , van Hulsteijn, Leonie , Dekkers, Olaf M , Faubion, Stephanie S. , Hirschberg, Angelica Lindén , Lambrinoudaki, Ιrene
European Journal of Endocrinology | October 13, 2025 | Volume: 193 | Issue: 4 | Pages: G49-G81
Abstract Women make up 51% of the world's population, and the global population of postmenopausal women is growing. About 25% of these women experience debilitating menopausal symptoms. Since it is important that all health care professionals have a fundamental knowledge of managing women presenting with symptoms related to the menopause, this European Society of Endocrinology Clinical Practice Guideline was developed. It provides guidance on evaluation and optimal clinical management of women who go through the menopause in middle age, those with Premature Ovarian Insufficiency (POI), Early Menopause and those for whom hormones are not appropriate, including women with, or at high risk of, breast cancer. This guideline discusses the benefits and risks of hormone therapy administration as well as summarizing other treatments for menopausal symptoms. Further, the contentious issue of the impact of menopausal hormone therapy in the prevention of chronic disease is considered.